These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Treatment of bleeding complications due to oral anticoagulant drugs]. Riess H Laryngorhinootologie; 2015 Oct; 94(10):697-709. PubMed ID: 26468622 [No Abstract] [Full Text] [Related]
9. [Management of bleeding associated with direct oral anticoagulants: update on reversal strategies]. Enríquez A; Baranchuk A; Corbalán R Rev Med Chil; 2019; 147(1):73-82. PubMed ID: 30848768 [TBL] [Abstract][Full Text] [Related]
10. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices? Alamneh EA; Chalmers L; Bereznicki LR Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063 [TBL] [Abstract][Full Text] [Related]
11. An update on the bleeding risks associated with DOACs. Drug Ther Bull; 2017 Nov; 55(11):129-132. PubMed ID: 29117993 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients-Analysis of Pharmaceuticals and Medical Devices Agency Data. Terayama Y J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1171-1181. PubMed ID: 28169097 [TBL] [Abstract][Full Text] [Related]
13. Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review. Alcocer L Am J Cardiovasc Drugs; 2016 Jun; 16(3):171-82. PubMed ID: 26923792 [TBL] [Abstract][Full Text] [Related]
14. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation. Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261 [TBL] [Abstract][Full Text] [Related]
15. Bleeding management in patients with new oral anticoagulants. Vargas M; Marra A; Perrone A; Servillo G Minerva Anestesiol; 2016 Aug; 82(8):884-94. PubMed ID: 27124307 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack. Coleman CI; Peacock WF; Bunz TJ; Alberts MJ Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814 [TBL] [Abstract][Full Text] [Related]
17. Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug Interactions. Pan EY; Sobieraj DM Conn Med; 2016 Feb; 80(2):105-11. PubMed ID: 27024982 [No Abstract] [Full Text] [Related]
19. Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants. Sivolella S; De Biagi M; Brunello G; Berengo M; Pengo V Odontology; 2015 Sep; 103(3):258-63. PubMed ID: 25656043 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation. Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]